181 related articles for article (PubMed ID: 3490224)
1. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
[TBL] [Abstract][Full Text] [Related]
2. Difference in prognosis between T- and B-cell lymphomas: clinical study at Shikoku Cancer Center Hospital.
Toki H; Okabe K; Kimura Y; Yumoto Y; Morita M; Ogushi I; Koike S; Takashima S; Sato G; Moriwaki S
Jpn J Clin Oncol; 1986 Mar; 16(1):41-8. PubMed ID: 3486301
[TBL] [Abstract][Full Text] [Related]
3. [Surface markers and prognostic relevance of non-Hodgkin's lymphoma--clinical studies of lymphoma patients at the Shikoku Cancer Center Hospital].
Toki H; Ishikawa M; Moriwaki S
Gan No Rinsho; 1983 Aug; 29(9):991-4. PubMed ID: 6620575
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of immunophenotype in aggressive non-Hodgkin's lymphoma.
Tsartsidze E; Betaneli M
Georgian Med News; 2006 May; (134):107-9. PubMed ID: 16783081
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
6. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
7. Immunological markers in non-Hodgkin's lymphomas.
Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
[TBL] [Abstract][Full Text] [Related]
9. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.
Kalyan K; Basu D; Soundararaghavan J
Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin's lymphomas of the lung. A study of 19 cases emphasizing the utility of frozen section immunologic studies in differential diagnosis.
Weiss LM; Yousem SA; Warnke RA
Am J Surg Pathol; 1985 Jul; 9(7):480-90. PubMed ID: 3879107
[TBL] [Abstract][Full Text] [Related]
12. [Lymphocyte surface markers during treatment of non-Hodgkin's lymphomas].
Trepińska E; Burchardt K
Z Gesamte Inn Med; 1981 Sep; 36(18):681-2. PubMed ID: 6976047
[No Abstract] [Full Text] [Related]
13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
14. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
[TBL] [Abstract][Full Text] [Related]
15. Analysis of local control in patients with non-Hodgkin's lymphoma according to the WHO classification.
Sakata K; Satoh M; Someya M; Nagakura H; Oouchi A; Nakata K; Kogawa K; Koito K; Hareyama M; Himi T
Strahlenther Onkol; 2005 Jun; 181(6):385-91. PubMed ID: 15925981
[TBL] [Abstract][Full Text] [Related]
16. Surface marker identification of small cleaved follicular center cell lymphomas with a highly favorable prognosis.
Rudders RA; Ahl ET; Delellis RA; Bernstein S; Begg CB
Cancer Res; 1982 Jan; 42(1):349-53. PubMed ID: 7053861
[TBL] [Abstract][Full Text] [Related]
17. Immunologic classification of non-Hodgkin's lymphomas: current status.
Seligmann M; Brouet JC; Preud'homme JL
Cancer Treat Rep; 1977 Sep; 61(6):1179-83. PubMed ID: 332351
[No Abstract] [Full Text] [Related]
18. Surface membrane phenotypic expression and treatment response of malignant lymphomas.
Lauder I; Bird CC; Child JA; Grigor I
J Pathol; 1985 Mar; 145(3):259-68. PubMed ID: 3920370
[TBL] [Abstract][Full Text] [Related]
19. Immunologic surface markers in non-Hodgkin's lymphomas.
Cossman J; Schnitzer B; Deegan MJ
Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504
[TBL] [Abstract][Full Text] [Related]
20. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
